A recent large-scale study involving 28,864 participants confirmed this trend, reporting increased AD risk associated with APOE ε4 carriage and markedly decreased risk among APOE ε2 carriers, especially in APOE ε2 homozygotes [15]. Here, APOE is linked to Alzheimer disease.